Top

Published in:

01-01-2017 | Original Article

Analysis of DNA Repair Genes Polymorphisms in Breast Cancer

Authors: Hanna Romanowicz, Łukasz Pyziak, Filip Jabłoński, Magdalena Bryś, Ewa Forma, Beata Smolarz

Published in: Pathology & Oncology Research | Issue 1/2017

Abstract

Genetic polymorphisms in the DNA repair genes may be associated with increased cancer risk. The purpose of this study was to evaluate the association of the DNA repair genes polymorphisms with the risk of breast cancer development. The study included 200 breast cancer patients and 200 healthy controls. The following polymorphisms were studied: C/G (Ser326Cys, rs1052133) of the hOGG1, A/C (IVS5 + 33, rs3212961) of the ERCC1, A/C (Lys939Gln, rs2228001) of the XPC, C/T (Thr241Met, rs861539) of the XRCC3, G/T (Leu787Leu, rs1800392) of the WRN and G/T (Ser307Ser, rs1056503) of the XRCC4 gene. Presented study showed statistically significant increase in the breast cancer development risk of the G/G hOGG1 genotype (OR 8.13; 95 % CI, 4.37–15.14; p < 0.001) and for the G hOGG1 allele (OR 5.11; 95 % CI, 3.69–7.06; p < 0.001), as well as for the C/C ERCC1 genotype (OR 10.61; 95 % CI, 5.72–19.69; p < 0.001) and the C ERCC1 allele (OR 4.66; 95 % CI, 3.43–6.34; p < 0.001) in patients with breast cancer in comparison with healthy control group. We also observed positive association of the C/C XPC genotype (OR 3.80; 95 % CI, 2.27–6.38; p < 0.001) as well as the C XPC allele occurrence with an increased breast cancer development risk (OR 2.65; 95 % CI, 1.98–3.55; p < 0.001). Furthermore, we found an association of the G/T WRN gene polymorphism with increased risk of carcinoma. The hOGG1, ERCC1, XPC and WRN genes polymorphisms may be related to development of breast cancer.

Yeo B, Turner N, Jones A (2014) An update on the medical management of breast cancer. BMJ 348:g3608CrossRefPubMed

Helleday T, Petermann E, Lundin C, Hodgson B, Sharma R (2008) DNA repair pathways as targets for cancer therapy. Nat Rev Cancer 8:193–204CrossRefPubMed

Matta J, Echenique M, Negron E, Morales L, Vargas W, Gaetan FS, Lizardi ER, Torres A, Rosado JO, Bolaños G, Cruz JG, Laboy J, Barnes R, Medina SS, Romero A, Martinez R, Dutil J, Suarez E, Alvarez-Garriga C, Bayona M (2012) The association of DNA repair with breast cancer risk in women. A comparative observational study. BMC Cancer 12:490CrossRefPubMedPubMedCentral

Melis JP, van Steeg H, Luijten M (2013) Oxidative DNA damage and nucleotide excision repair. Antioxid Redox Signal 18:2409–2419CrossRefPubMedPubMedCentral

Larrea AA, Lujan SA, Kunkel TA (2010) DNA mismatch repair. Cell 141:730CrossRefPubMed

Brandsma I, Gent DC (2012) Pathway choice in DNA double strand break repair: observations of a balancing act. Genome Integr 3:9CrossRefPubMedPubMedCentral

Truong LN, Li Y, Shi LZ, Hwang PY, He J, Wang H, Razavian N, Berns MW, Wu X (2013) Microhomology-mediated end joining and homologous recombination share the initial end resection step to repair DNA double-strand breaks in mammalian cells. Proc Natl Acad Sci U S A 110:7720–7725CrossRefPubMedPubMedCentral

Huang C-S, Chen J-J, Yang S-Y, Cheng C-W, Chern H-D, Chang K-J, Wu P-E, Shen C-Y (2004) Breast Cancer Risk Associated with Genotypic Polymorphism of Oxidative DNA Damage Repair Genes - A Multigenic Study of Base Excision Repair and Transcription-Coupled Repair in Cancer Susceptibility. Journal of Genetics and Molecular Biology 15:116–136

Butkiewicz D, Rusin M, Enewold L, Shields PG, Chorazy M, Harris CC (2001) Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis 22:593–597CrossRefPubMed

10.

Lu AL, Li X, Gu Y, Wright PM, Chang DY (2001) Repair of oxidative DNA damage: mechanisms and functions. Cell Biochem Biophys 35:141–170CrossRefPubMed

11.

Park J, Chen L, Tockman MS, Elahi A, Lazarus P (2004) The human 8-oxoguanine DNA N-glycosylase 1 (hOGG1) DNA repair enzyme and its association with lung cancer risk. Pharmacogenetics 14:103–109CrossRefPubMed

12.

Sinha RP, Häder DP (2002) UV-induced DNA damage and repair: a review. Photochem Photobiol Sci 1:225–236CrossRefPubMed

13.

Yang J, Liu X, Niu P, Zou Y, Gong Z, Yuan J, Wu T (2007) Dynamic changes of XPA, XPC, XPF, XPG and ERCC1 protein expression and their correlations with levels of DNA damage in human bronchial epithelia cells exposed to benzo[a]pyrene. Toxicol Lett 174:10–17CrossRefPubMed

14.

Pierce AJ, Johnson RD, Thompson LH, Jasin M (1999) XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev 13:2633–2638CrossRefPubMedPubMedCentral

15.

Brosh RM Jr (2013) DNA helicases involved in DNA repair and their roles in cancer. Nat Rev Cancer 13:542–558CrossRefPubMedPubMedCentral

16.

Junop MS, Modesti M, Guarné A, Ghirlando R, Gellert M, Yang W (2000) Crystal structure of the Xrcc4 DNA repair protein and implications for end joining. EMBO J 19:5962–5970CrossRefPubMedPubMedCentral

17.

Sterpone S, Mastellone V, Padua L, Novelli F, Patrono C, Cornetta T, Giammarino D, Donato V, Testa A, Cozzi R (2010) Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol 136:631–636CrossRefPubMed

18.

Romanowicz-Makowska H, Smolarz B, Makowski M, Polac I, Pertynski T (2008) Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women. Pol J Pathol 59:201–204PubMed

19.

Synowiec E, Stefanska J, Morawiec Z, Blasiak J, Wozniak K (2008) Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients. Mutat Res 648:65–72CrossRefPubMed

20.

Sangrajrang S, Schmezer P, Burkholder I, Waas P, Boffetta P, Brennan P, Bartsch H, Wiangnon S, Popanda O (2008) Polymorphisms in three base excision repair genes and breast cancer risk in Thai women. Breast Cancer Res Treat 111:279–288CrossRefPubMed

21.

Cai Q, Shu XO, Wen W, Courtney R, Dai Q, Gao YT, Zheng W (2006) Functional Ser326Cys polymorphism in the hOGG1 gene is not associated with breast cancer risk. Cancer Epidemiol Biomark Prev 15:403–404CrossRef

22.

Zhang Y, Newcomb PA, Egan KM, Titus-Ernstoff L, Chanock S, Welch R, Brinton LA, Lissowska J, Bardin-Mikolajczak A, Peplonska B, Szeszenia-Dabrowska N, Zatonski W, Garcia-Closas M (2006) Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomark Prev 15:353–358CrossRef

23.

Loizidou MA, Michael T, Neuhausen SL, Newbold RF, Marcou Y, Kakouri E, Daniel M, Papadopoulos P, Malas S, Hadjisavvas A, Kyriacou K (2009) DNA-repair genetic polymorphisms and risk of breast cancer in Cyprus. Breast Cancer Res Treat 115:623–627CrossRefPubMed

24.

Roberts MR, Shields PG, Ambrosone CB, Nie J, Marian C, Krishnan SS, Goerlitz DS, Modali R, Seddon M, Lehman T, Amend KL, Trevisan M, Edge SB, Freudenheim JL (2011) Single-nucleotide polymorphisms in DNA repair genes and association with breast cancer risk in the web study. Carcinogenesis 32:1223–1230CrossRefPubMedPubMedCentral

25.

Dhillon VS, Yeoh E, Fenech M (2011) DNA repair gene polymorphisms and prostate cancer risk in South Australia-results of a pilot study. Urol Oncol 29:641–646CrossRefPubMed

26.

Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL (2010) Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based study. Cancer Causes Control 21:289–300CrossRefPubMed

27.

Chen L, Elahi A, Pow-Sang J, Lazarus P, Park J (2003) Association between polymorphism of human oxoguanine glycosylase 1 and risk of prostate cancer. J Urol 170:2471–2474CrossRefPubMed

28.

Xu J, Zheng SL, Turner A, Isaacs SD, Wiley KE, Hawkins GA, Chang BL, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB (2002) Associations between hOGG1 sequence variants and prostate cancer susceptibility. Cancer Res 62:2253–2257PubMed

29.

Li D, Suzuki H, Liu B, Morris J, Liu J, Okazaki T, Li Y, Chang P, Abbruzzese JL (2009) DNA repair gene polymorphisms and risk of pancreatic cancer. Clin Cancer Res 15:740–746CrossRefPubMedPubMedCentral

30.

McWilliams RR, Bamlet WR, Cunningham JM, Goode EL, de Andrade M, Boardman LA, Petersen GM (2008) Polymorphisms in DNA repair genes, smoking, and pancreatic adenocarcinoma risk. Cancer Res 68:4928–4935CrossRefPubMedPubMedCentral

31.

Gangwar R, Ahirwar D, Mandhani A, Mittal RD (2009) Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the north Indian population? Mutat Res 680:56–63CrossRefPubMed

32.

Arizono K, Osada Y, Kuroda Y (2008) DNA repair gene hOGG1 codon 326 and XRCC1 codon 399 polymorphisms and bladder cancer risk in a Japanese population. Jpn J Clin Oncol 38:186–191CrossRefPubMed

33.

Karahalil B, Kocabas NA, Ozcelik T (2006) DNA repair gene polymorphisms and bladder cancer susceptibility in a Turkish population. Anticancer Res 26:4955–4958PubMed

34.

Srivastava A, Srivastava K, Pandey SN, Choudhuri G, Mittal B (2009) Single-nucleotide polymorphisms of DNA repair genes OGG1 and XRCC1: association with gallbladder cancer in north Indian population. Ann Surg Oncol 16:1695–1703CrossRefPubMed

35.

Engin AB, Karahalil B, Engin A, Karakaya AE (2011) DNA repair enzyme polymorphisms and oxidative stress in a Turkish population with gastric carcinoma. Mol Biol Rep 38:5379–5386CrossRefPubMed

36.

Palli D, Polidoro S, D’Errico M, Saieva C, Guarrera S, Calcagnile AS, Sera F, Allione A, Gemma S, Zanna I, Filomena A, Testai E, Caini S, Moretti R, Gomez-Miguel MJ, Nesi G, Luzzi I, Ottini L, Masala G, Matullo G, Dogliotti E (2010) Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis 25:569–575CrossRefPubMed

37.

Poplawski T, Arabski M, Kozirowska D, Blasinska-Morawiec M, Morawiec Z, Morawiec-Bajda A, Klupińska G, Jeziorski A, Chojnacki J, Blasiak J (2006) DNA damage and repair in gastric cancer–a correlation with the hOGG1 and RAD51 genes polymorphisms. Mutat Res 601:83–91CrossRefPubMed

38.

Brevik A, Joshi AD, Corral R, Onland-Moret NC, Siegmund KD, Le Marchand L, Baron JA, Martinez ME, Haile RW, Ahnen DJ, Sandler RS, Lance P, Stern MC (2010) Polymorphisms in base excision repair genes as colorectal cancer risk factors and modifiers of the effect of diets high in red meat. Cancer Epidemiol Biomark Prev 19:3167–3173CrossRef

39.

Stern MC, Conti DV, Siegmund KD, Corral R, Yuan JM, Koh WP, Yu MC (2007) DNA repair single-nucleotide polymorphisms in colorectal cancer and their role as modifiers of the effect of cigarette smoking and alcohol in the Singapore Chinese health study. Cancer Epidemiol Biomark Prev 16:2363–2372CrossRef

40.

Upadhyay R, Malik MA, Zargar SA, Mittal B (2010) OGG1 Ser326Cys polymorphism and susceptibility to esophageal cancer in low and high at-risk populations of northern India. J Gastrointest Cancer 41:110–115CrossRefPubMed

41.

Xing DY, Tan W, Song N, Lin DX (2001) Ser326Cys polymorphism in hOGG1 gene and risk of esophageal cancer in a Chinese population. Int J Cancer 95:140–143CrossRefPubMed

42.

Lan Q, Mumford JL, Shen M, Demarini DM, Bonner MR, He X, Yeager M, Welch R, Chanock S, Tian L, Chapman RS, Zheng T, Keohavong P, Caporaso N, Rothman N (2004) Oxidative damage-related genes AKR1C3 and OGG1 modulate risks for lung cancer due to exposure to PAH-rich coal combustion emissions. Carcinogenesis 25:2177–2181CrossRefPubMed

43.

Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K (2011) Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73:138–146CrossRefPubMed

44.

De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H (2007) Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res 631:101–110CrossRefPubMed

45.

Cho EY, Hildesheim A, Chen CJ, Hsu MM, Chen IH, Mittl BF, Levine PH, Liu MY, Chen JY, Brinton LA, Cheng YJ, Yang CS (2003) Nasopharyngeal carcinoma and genetic polymorphisms of DNA repair enzymes XRCC1 and hOGG1. Cancer Epidemiol Biomark Prev 12:1100–1104

46.

Elahi A, Zheng Z, Park J, Eyring K, McCaffrey T, Lazarus P (2002) The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis 23:1229–1234CrossRefPubMed

47.

Krupa R, Sobczuk A, Poplawski T, Wozniak K, Blasiak J (2011) DNA damage and repair in endometrial cancer in correlation with the hOGG1 and RAD51 genes polymorphism. Mol Biol Rep 38:1163–1170CrossRefPubMed

48.

Zhao H, Qin C, Yan F, Wu B, Cao Q, Wang M, Zhang Z, Yin C (2011) hOGG1 Ser326Cys polymorphism and renal cell carcinoma risk in a Chinese population. DNA Cell Biol 30:317–321CrossRefPubMed

49.

Li Q, Huang L, Rong L, Xue Y, Lu Q, Rui Y, Li J, Tong N, Wang M, Zhang Z, Fang Y (2011) hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population. Cancer Sci 102:1123–1127CrossRefPubMed

50.

Stanczyk M, Sliwinski T, Cuchra M, Zubowska M, Bielecka-Kowalska A, Kowalski M, Szemraj J, Mlynarski W, Majsterek I (2011) The association of polymorphisms in DNA base excision repair genes XRCC1, OGG1 and MUTYH with the risk of childhood acute lymphoblastic leukemia. Mol Biol Rep 38:445–451CrossRefPubMed

51.

Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, Eguchi Y, Yasutake T, Ozaki I, Yamamoto K, Onohara S, Kawazoe S, Shigematsu H, Koizumi S, Tanaka K (2006) hOGG1 Ser326Cys polymorphism and risk of hepatocellular carcinoma among Japanese. J Epidemiol 16:233–239CrossRefPubMed

52.

Dianzani I, Gibello L, Biava A, Giordano M, Bertolotti M, Betti M, Ferrante D, Guarrera S, Betta GP, Mirabelli D, Matullo G, Magnani C (2006) Polymorphisms in DNA repair genes as risk factors for asbestos-related malignant mesothelioma in a general population study. Mutat Res 599:124–134CrossRefPubMed

53.

Wei B, Zhou Y, Xu Z, Xi B, Cheng H, Ruan J, Zhu M, Hu Q, Wang Q, Wang Z, Yan Z, Jin K, Zhou D, Xuan F, Huang X, Shao J, Lu P (2011) The effect of hOGG1 Ser326Cys polymorphism on cancer risk: evidence from a meta-analysis. PLoS One 6:e27545CrossRefPubMedPubMedCentral

54.

Gu D, Wang M, Zhang Z, Chen J (2010) Lack of association between the hOGG1 Ser326Cys polymorphism and breast cancer risk: evidence from 11 case–control studies. Breast Cancer Res Treat 2010; 527–531.

55.

Guo XG, Wang Q2, Xia Y3, Zheng L (2015) The C8092A polymorphism in the ERCC1 gene and breast carcinoma risk: A meta-analysis of case-control studies. Int J Clin Exp Med 8: 3691–3699.

56.

Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ (2007) Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat 101:65–71CrossRefPubMed

57.

Wang Z, Xu Y, Tang J, Ma H, Qin J, Lu C, Wang X, Hu Z, Wang X, Shen H (2009) A polymorphism in Werner syndrome gene is associated with breast cancer susceptibility in Chinese women. Breast Cancer Res Treat 118:169–175CrossRefPubMed

58.

Sangrajrang S, Schmezer P, Burkholder I, Boffetta P, Brennan P, Woelfelschneider A, Bartsch H, Wiangnon S, Cheisilpa A, Popanda O (2007) The XRCC3 Thr241Met polymorphism and breast cancer risk: a case-control study in a Thai population. Biomarkers 12:523–532CrossRefPubMed

59.

Chiu CF, Wang HC, Wang CH, Wang CL, Lin CC, Shen CY, Chiang SY, Bau DT (2008) A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients. Anticancer Res 28:267–270PubMed

Title: Analysis of DNA Repair Genes Polymorphisms in Breast Cancer
Authors: Hanna Romanowicz
Łukasz Pyziak
Filip Jabłoński
Magdalena Bryś
Ewa Forma
Beata Smolarz
Publication date: 01-01-2017
Publisher: Springer Netherlands
Published in: Pathology & Oncology Research / Issue 1/2017
Print ISSN: 1219-4956
Electronic ISSN: 1532-2807
DOI: https://doi.org/10.1007/s12253-016-0110-5

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Mutation Profile of B-Raf Gene Analyzed by fully Automated System and Clinical Features in Japanese Melanoma Patients

Intratumoral Heterogeneity of Frameshift Mutations in MECOM Gene is Frequent in Colorectal Cancers with High Microsatellite Instability

Expression Levels of Warburg-Effect Related microRNAs Correlate with each Other and that of Histone Deacetylase Enzymes in Adult Hematological Malignancies with Emphasis on Acute Myeloid Leukemia

Diagnostic Biomarkers in Oral Verrucous Carcinoma: A Systematic Review

Effects of Mesalazine on Morphological and Functional Changes in the Indomethacin-Induced Inflammatory Bowel Disease (Rat Model of Crohn’s Disease)

Biologic Evaluation of Diabetes and Local Recurrence in Non-Small Cell Lung Cancer

Keynote webinar | Spotlight on antibody–drug conjugates in cancer